| Recruiting | Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy) Relapsed / Refractory Osteosarcoma | Phase 1 / Phase 2 | 2026-02-01 |
| Withdrawn | Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC Clear Cell Renal Cell Carcinoma | Phase 2 / Phase 3 | 2025-11-01 |
| Recruiting | 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer Metastatic Sarcoma, Esophageal Cancer, Gastric Cancer | Phase 1 / Phase 2 | 2025-08-01 |
| Active Not Recruiting | PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer Prostate Cancer | Phase 4 | 2024-02-08 |
| Completed | DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY Cardiac Disease | Phase 3 | 2018-12-28 |
| Completed | DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY Cardiac Disease | Phase 3 | 2018-10-24 |
| Withdrawn | A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Ar Coronary Artery Disease (CAD) | — | 2013-03-01 |
| Withdrawn | Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI Coronary Artery Disease | Phase 3 | 2012-11-01 |
| Completed | A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Coronary Artery Disease | Phase 3 | 2011-06-01 |
| Withdrawn | Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillat Heart Failure | Phase 2 | 2010-05-01 |
| Completed | Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR Nephrogenic Systemic Fibrosis | — | 2009-10-01 |
| Completed | A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Pat Heart Failure | Phase 1 | 2009-08-01 |
| Completed | A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure Pulmonary Heart Disease | Phase 4 | 2009-07-01 |
| Completed | Study of [3H] BMS747158 in Healthy Male Subjects Coronary Artery Disease | Phase 1 | 2009-06-01 |
| Completed | Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158 Ischemia | Phase 2 | 2009-01-01 |
| Completed | A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stres Healthy Volunteers | Phase 1 | 2008-06-01 |
| Completed | Retrospective Safety Study to Compare Mortality in Intensive Care Unite (ICU) Patients Undergoing Echocardiogr Cardiovascular Disease | — | 2008-06-01 |
| Completed | A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice Cardiovascular Disease | Phase 4 | 2008-02-01 |
| Completed | A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158 Healthy | Phase 1 | 2007-09-01 |
| Completed | DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography Ventricular Ejection Fraction | Phase 4 | 2006-07-01 |
| Completed | A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease Kawasaki Disease | Phase 3 | 2005-08-01 |
| Completed | A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects Kawasaki Disease | Phase 1 / Phase 2 | 2005-01-01 |
| Completed | CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI Myocardial Infarction | Phase 4 | 2005-01-01 |
| Completed | Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by An Diabetes Mellitus, Type 2, Coronary Restenosis | Phase 4 | 2004-04-01 |
| Completed | A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease Coronary Artery Disease, Heart Disease | Phase 4 | 2004-04-01 |
| Completed | A Phase II Study of DMP 115 to Assess Focal Liver Lesions Liver Disease | Phase 2 | 2004-03-01 |
| Completed | A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease. Diabetes | Phase 4 | 2003-12-01 |
| Temporarily Not Available | Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PS Castration-Resistant Prostatic Cancer | — | — |